Welcome to our dedicated page for Alexandria Real Estate Eq news (Ticker: ARE), a resource for investors and traders seeking the latest updates and insights on Alexandria Real Estate Eq stock.
Alexandria Real Estate Equities, Inc. (NYSE: ARE) is an S&P 500 life science REIT that regularly issues detailed updates on its operations, leasing activity, capital allocation, and Megacampus™ developments. The news flow for Alexandria reflects its role as an owner, operator, and developer of Class A/A+ properties in major life science innovation clusters, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.
On this page, readers can follow company announcements about quarterly and year-end operating and financial results, including metrics such as funds from operations (FFO), net operating income, occupancy, leasing volume, and development pipeline progress. Alexandria frequently reports on large leases, such as long-term build-to-suit research hubs on its Campus Point and One Alexandria Square Megacampus ecosystems, as well as tenant collections, rental rate changes, and same property performance.
News items also cover Board decisions on quarterly cash dividends, explanations of dividend strategy in the context of liquidity and balance sheet strength, and authorizations or extensions of common stock repurchase programs. Investors can review how the company describes its capital recycling strategy, including dispositions of non-core assets, land sales, and partial interest sales intended to fund construction and manage leverage.
Beyond financial reporting, Alexandria’s releases highlight partnerships and recognitions within the broader life science ecosystem. Examples include strategic collaborations with large pharmaceutical companies on shared innovation hubs and awards from organizations such as the Foundation for the National Institutes of Health recognizing contributions to biomedical innovation. For ongoing context around ARE’s performance, strategy, and sector role, this news feed aggregates the company’s official press releases and related disclosures.
Alexandria Real Estate Equities (NYSE: ARE) priced a public offering of $750,000,000 aggregate principal amount of 5.25% senior notes due 2036 at 99.679% with a yield to maturity of 5.291%. The notes are unsecured and fully guaranteed by an indirectly 100% owned subsidiary.
Closing is expected on or about February 25, 2026. Net proceeds are expected to repay commercial paper used in connection with repurchase or redemption of certain outstanding notes aggregating $952,202,784.40, with any remaining proceeds used for short-term investments or general corporate purposes.
Alexandria Real Estate Equities (NYSE: ARE) announced pricing and terms for cash tender offers to purchase up to an Aggregate Maximum Tender Amount of $952,202,784.40 of its 2050, 2051 and 2052 senior notes.
Key terms: Early Tender Date Feb 9, 2026; Early Settlement Date expected Feb 12, 2026; Early Tender Premium $50 per $1,000; Total Consideration per $1,000: $656.22 (2051), $726.53 (2052), $790.86 (2050). Acceptance priority levels and financing conditions apply.
Alexandria Real Estate Equities (NYSE: ARE) announced an underwritten public offering of senior notes on Feb 10, 2026. The notes will be unsecured obligations of the company and fully guaranteed by an indirectly 100% owned subsidiary. Net proceeds are expected to repay commercial paper used in a prior cash tender offer; pending use proceeds may be invested in short-term securities or used for general corporate purposes.
Alexandria Real Estate Equities (NYSE: ARE) reported early results of cash tender offers for its 2050, 2051 and 2052 senior notes and has increased the Aggregate Maximum Tender Amount to accept all Notes validly tendered and not withdrawn as of the Early Tender Date (Feb 9, 2026).
As of 5:00 p.m. ET on Feb 9, 2026, holders tendered $497.602M of 3.000% notes due 2051, $524.594M of 3.550% notes due 2052 and $309.199M of 4.000% notes due 2050. Acceptance remains subject to financing conditions.
Alexandria Real Estate Equities (NYSE: ARE) commenced cash tender offers to purchase up to an aggregate purchase price not to exceed $800,000,000 of its outstanding 2051, 2052 and 2050 senior notes.
Offers include an Early Tender Premium of $50 per $1,000, fixed spreads of +75–+80 bps over a 4.750% U.S. Treasury reference, priority acceptance levels, expected settlement in February 2026 and a $500,000,000 financing condition.
Alexandria Real Estate Equities (NYSE: ARE) reported results for the quarter and year ended December 31, 2025. Net loss per diluted share was $(6.35) for 4Q25 and $(8.44) for 2025, while FFO per diluted share, as adjusted was $2.16 for 4Q25 and $9.01 for 2025. The company ended 2025 with 90.9% operating occupancy, $5.30 billion of liquidity, and net debt plus preferred to Adjusted EBITDA of 5.7x (4Q25 annualized).
Actions included a 45% reduction in the quarterly common dividend to $0.72, $1.81 billion of dispositions in 2025, a $500 million repurchase authorization, and reiterated 2026 FFO guidance of $6.25–$6.55 per share.
Alexandria Real Estate Equities (NYSE: ARE) reported the tax composition of its 2025 distributions. Total distributions paid were $5.280000 per share (four quarterly payments of $1.32 each). The taxable ordinary dividend component (Box 1a) totaled $3.517008 per share, representing 66.61% of the total. Qualified dividend amounts totaled $0.762960 per share. Return of capital was $0.033264 per share and Section 199A dividends totaled $0.250008 per share. No Section 897 capital gains were reported. Stockholders are advised to consult their tax advisors for individual treatment.
Alexandria Real Estate Equities (NYSE: ARE) marked its 32nd anniversary on Jan 5, 2026, highlighting its role as a pioneer in life science real estate and Megacampus ecosystems that support drug development and innovation.
Key reported metrics through Sept 30, 2025: 71% of annual rental revenue came from Greater Boston, San Francisco Bay Area, and San Diego; Megacampus occupancy was 91% (+18% vs. market); combined leasing volume in those three markets equaled ~105% of the next five largest owners from Jan 1, 2023–Sept 30, 2025; and five-year average tenant retention exceeded 80%. The company also said 39% of the 44 novel therapies approved by FDA in 2025 were developed or commercialized by Alexandria tenants.
Alexandria plans a public-private partnership MAP-D clinical study targeting a May 2026 launch to identify biomarkers for depression.
Alexandria Real Estate Equities (NYSE: ARE) will host a conference call and audio webcast on Tuesday, January 27, 2026 at 2:00 p.m. ET to discuss its fourth quarter and year end 2025 operating and financial results.
The company will release results after market close on Monday, January 26, 2026. To join the live call dial (833) 366-1125 (U.S./Canada) or (412) 902-6738 (international) and ask the operator for Alexandria Real Estate Equities. The live webcast is available at http://investor.are.com/webcasts.
A replay is available from 4:00 p.m. ET on January 27, 2026 through 4:00 p.m. ET on February 3, 2026; dial (855) 669-9658 (U.S./Canada) or (412) 317-0088 (international) and enter access code 4730896.
Alexandria Real Estate Equities (NYSE: ARE) announced that its Board authorized a refreshed common stock repurchase program of up to $500 million, replacing the prior authorization that was set to expire December 31, 2025.
Under the prior program the company repurchased $258.2 million of common stock, primarily in January 2025. The new authorization permits purchases in the open market or by negotiated transactions, accelerated share repurchases, indirect purchases including derivatives, or other transactions through December 31, 2026. Repurchases are discretionary, may be suspended, and will depend on price, available capital, market and economic conditions. The company said its preference is to fund repurchases on a leverage-neutral basis using operating cash after dividends and proceeds from property dispositions or joint ventures.
FAQ
What is the current stock price of Alexandria Real Estate Eq (ARE)?
What is the market cap of Alexandria Real Estate Eq (ARE)?
